Cognitive Hegemony: The True Objective of Russia’s New Active Measures
Intelligence Info · 2025
DOI: 10.58679/ii21012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Intelligence Info, 2025. Verfasst von Bogdan-George Rădulescu.
Abstract (Originalsprache)
The traditional tactics of Soviet destabilization have evolved under Putin’s leadership, taking on new and more insidious forms. Russia’s ongoing commitment to the Soviet-era strategy of "active measures"—now employed in subtler ways—remains central to its foreign policy objectives. A destabilized West is less likely to focus on Moscow’s political and geopolitical transgressions, or on its military actions that openly challenge the liberal international order. This article examines the covert aspects of Russia’s political warfare aimed at undermining Western stability. The Kremlin’s priority of fracturing solidarity within the European Union and weakening transatlantic relations—especially in light of the unified economic sanctions imposed on Russia by the U.S. and EU over its aggressive war against sovereign Ukraine—compels Russian security agencies to adapt their "active measures" to new global realities. We explore key tactics and strategies employed by Russia in its covert confrontation with major Western institutions, such as the EU and NATO. Ultimately, we aim to deconstruct how the Soviet concept of "active measures" and the notion of "political warfare" have become nearly synonymous, fitting within the broader and evolving framework of "hybrid warfare."
Zitieren
APA
Rădulescu, B. (2025). Cognitive Hegemony: The True Objective of Russia’s New Active Measures. Intelligence Info. https://doi.org/10.58679/ii21012
Vancouver
Rădulescu B. Cognitive Hegemony: The True Objective of Russia’s New Active Measures. Intelligence Info. 2025. doi:10.58679/ii21012
BibTeX
@article{Rdulescu2025,
author = {Rădulescu, Bogdan-George},
title = {Cognitive Hegemony: The True Objective of Russia’s New Active Measures},
journal = {Intelligence Info},
year = {2025},
doi = {10.58679/ii21012}
}
EUVIMED